Uday Kompella - Jun 25, 2021 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role: Director
Signature: /s/ Uday Kompella by Sanjay Subramanian, his attorney-in-fact
Stock symbol: OCGN
Transactions as of: Jun 25, 2021
Transactions value $: -$63,045
Form type: 4
Date filed: 6/25/2021, 04:17 PM
Previous filing: Jun 1, 2021
Next filing: Jul 30, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCGN	Common Stock	Options Exercise	$18.3K	+10K	+1.82%	$1.83	561K	Jun 25, 2021	Direct
transaction	OCGN	Common Stock	Sale	-$81.3K	-10K	-1.78%	$8.13	551K	Jun 25, 2021	Direct	F1, F2
holding	OCGN	Common Stock						479K	Jun 25, 2021	By: Kompella LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCGN	Option (right to buy)	Options Exercise	$0	-10K	-7.94%	$0.00	116K	Jun 25, 2021	Common Stock	10K	$1.83	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.07 to $8.20. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3	17,500 shares under the option are exercisable. The option, initially representing a right to purchase a total of 126,000 shares, vests and becomes exercisable in equal monthly installments over three years commencing on February 2, 2021, subject to continued service with the Company on the applicable vesting dates.